抗肿瘤药-话题@MedSci

#抗肿瘤药#

85篇内容 | 2884人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1593722, encodeId=f9d41593e22ca, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=专家呼吁关注抗肿瘤药全生命周期管理建立和完善质量管理体系, objectType=article, longId=197888, objectId=11e419e88810, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11e419e88810, replyNumber=0, likeNumber=69, createdTime=2020-07-23, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11e419e88810, moduleTitle=专家呼吁关注抗肿瘤药全生命周期管理建立和完善质量管理体系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11e419e88810)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593721, encodeId=3b1a1593e2163, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=关于公开征求《抗肿瘤药联合治疗临床试验技术指导原则》意见的通知, objectType=article, longId=197705, objectId=a79a19e70511, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a79a19e70511, replyNumber=0, likeNumber=70, createdTime=2020-07-19, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a79a19e70511, moduleTitle=关于公开征求《抗肿瘤药联合治疗临床试验技术指导原则》意见的通知, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a79a19e70511)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593720, encodeId=c3991593e200c, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=FDA批准抗肿瘤药物PI3Kα抑制剂CYH33临床试验, objectType=article, longId=196559, objectId=e8de1965590d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8de1965590d, replyNumber=0, likeNumber=77, createdTime=2020-06-28, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8de1965590d, moduleTitle=FDA批准抗肿瘤药物PI3Kα抑制剂CYH33临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8de1965590d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593719, encodeId=2af31593e197d, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=FDA批准抗肿瘤药物IDH1抑制剂HH2301临床试验, objectType=article, longId=196558, objectId=65c9196558ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65c9196558ff, replyNumber=0, likeNumber=74, createdTime=2020-06-28, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65c9196558ff, moduleTitle=FDA批准抗肿瘤药物IDH1抑制剂HH2301临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65c9196558ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593718, encodeId=f5321593e18a9, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=FDA指南简介：拓展队列用于首次人体试验加速抗肿瘤药物/生物制剂的开发, objectType=article, longId=193976, objectId=40ab1939e692, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40ab1939e692, replyNumber=0, likeNumber=66, createdTime=2020-05-13, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40ab1939e692, moduleTitle=FDA指南简介：拓展队列用于首次人体试验加速抗肿瘤药物/生物制剂的开发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40ab1939e692)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593717, encodeId=37071593e17d0, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=抗肿瘤药物临床试验中风险评估与应对措施的探讨, objectType=article, longId=191066, objectId=430b191066c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=430b191066c8, replyNumber=0, likeNumber=92, createdTime=2020-03-31, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=430b191066c8, moduleTitle=抗肿瘤药物临床试验中风险评估与应对措施的探讨, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=430b191066c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593716, encodeId=34a11593e1619, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=抗肿瘤药物临床试验的特点和医学伦理问题, objectType=article, longId=191059, objectId=d683191059eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d683191059eb, replyNumber=0, likeNumber=89, createdTime=2020-03-31, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d683191059eb, moduleTitle=抗肿瘤药物临床试验的特点和医学伦理问题, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d683191059eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593715, encodeId=2fb71593e1529, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=林根教授谈新冠肺炎疫情逐步控制下肺癌患者的诊疗建议，推荐合适的患者接受口服抗肿瘤药物治疗, objectType=article, longId=190197, objectId=f41f19019e2a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f41f19019e2a, replyNumber=0, likeNumber=74, createdTime=2020-03-19, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f41f19019e2a, moduleTitle=林根教授谈新冠肺炎疫情逐步控制下肺癌患者的诊疗建议，推荐合适的患者接受口服抗肿瘤药物治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f41f19019e2a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593714, encodeId=e7261593e1470, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=新型抗肿瘤药物临床应用指导原则（2019版）, objectType=article, longId=190150, objectId=bc2f190150bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc2f190150bd, replyNumber=0, likeNumber=90, createdTime=2020-03-18, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc2f190150bd, moduleTitle=新型抗肿瘤药物临床应用指导原则（2019版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc2f190150bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593713, encodeId=78141593e13f3, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=抗肿瘤药临床试验的统计设计分析, objectType=article, longId=190119, objectId=641e19011966, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=641e19011966, replyNumber=0, likeNumber=94, createdTime=2020-03-18, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=641e19011966, moduleTitle=抗肿瘤药临床试验的统计设计分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=641e19011966)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593712, encodeId=df851593e121f, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=王子平教授：力争防控同时保证肿瘤患者能够有序诊疗，安罗替尼等口服抗肿瘤药物在疫情期间发挥重要作用, objectType=article, longId=189805, objectId=e2d418980531, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e2d418980531, replyNumber=0, likeNumber=69, createdTime=2020-03-13, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e2d418980531, moduleTitle=王子平教授：力争防控同时保证肿瘤患者能够有序诊疗，安罗替尼等口服抗肿瘤药物在疫情期间发挥重要作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e2d418980531)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593711, encodeId=4efe1593e1182, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=2019 年 FDA 批准上市的抗肿瘤药, objectType=article, longId=185751, objectId=4ed9185e5175, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ed9185e5175, replyNumber=0, likeNumber=67, createdTime=2020-01-07, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ed9185e5175, moduleTitle=2019 年 FDA 批准上市的抗肿瘤药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ed9185e5175)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593710, encodeId=b5361593e1016, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=新型抗肿瘤药物临床应用指导原则（2019年版）, objectType=article, longId=185023, objectId=53921850232f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53921850232f, replyNumber=0, likeNumber=74, createdTime=2019-12-22, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53921850232f, moduleTitle=新型抗肿瘤药物临床应用指导原则（2019年版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53921850232f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593709, encodeId=bf311593e093c, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=可及性实用性兼具升级版《消化系统抗肿瘤药物合理用药指南》在京发布, objectType=article, longId=184820, objectId=1fe71848207f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1fe71848207f, replyNumber=0, likeNumber=70, createdTime=2019-12-17, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1fe71848207f, moduleTitle=可及性实用性兼具升级版《消化系统抗肿瘤药物合理用药指南》在京发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1fe71848207f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593708, encodeId=8c2f1593e08a8, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=抗肿瘤药联合用药的早期临床方案设计思路及主要问题｜2019DDI, objectType=article, longId=182186, objectId=4dcc182186f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4dcc182186f2, replyNumber=0, likeNumber=69, createdTime=2019-11-01, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4dcc182186f2, moduleTitle=抗肿瘤药联合用药的早期临床方案设计思路及主要问题｜2019DDI, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4dcc182186f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593707, encodeId=80181593e079c, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=2019 CSCO 大咖发声：国内自主研发抗肿瘤药物研发“全面开花”, objectType=article, longId=181293, objectId=b6141812936b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6141812936b, replyNumber=0, likeNumber=80, createdTime=2019-10-17, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6141812936b, moduleTitle=2019 CSCO 大咖发声：国内自主研发抗肿瘤药物研发“全面开花”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6141812936b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593706, encodeId=1fa91593e06e3, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=2019 CSCO 大咖发声：国内自主研发抗肿瘤药物研发“全面开花”, objectType=article, longId=181179, objectId=d68a1811e971, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d68a1811e971, replyNumber=0, likeNumber=97, createdTime=2019-10-16, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d68a1811e971, moduleTitle=2019 CSCO 大咖发声：国内自主研发抗肿瘤药物研发“全面开花”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d68a1811e971)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593705, encodeId=39801593e0572, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=抗肿瘤药物处方审核专家共识——结直肠癌, objectType=article, longId=180231, objectId=68ea1802315e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68ea1802315e, replyNumber=0, likeNumber=70, createdTime=2019-09-30, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68ea1802315e, moduleTitle=抗肿瘤药物处方审核专家共识——结直肠癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68ea1802315e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593704, encodeId=60de1593e04b9, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=BMJ：2014-16年间EMA批准抗肿瘤药物临床关键试验偏倚风险研究, objectType=article, longId=179936, objectId=fca71e993682, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fca71e993682, replyNumber=0, likeNumber=63, createdTime=2019-09-25, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fca71e993682, moduleTitle=BMJ：2014-16年间EMA批准抗肿瘤药物临床关键试验偏倚风险研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fca71e993682)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593703, encodeId=3ade1593e0305, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=Lancet Oncol：FDA批准抗肿瘤药物临床试验质量分析, objectType=article, longId=175095, objectId=b12c1e5095ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b12c1e5095ac, replyNumber=0, likeNumber=62, createdTime=2019-07-11, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b12c1e5095ac, moduleTitle=Lancet Oncol：FDA批准抗肿瘤药物临床试验质量分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b12c1e5095ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

抗肿瘤药

2020-05-29

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

专家呼吁关注抗肿瘤药全生命周期管理建立和完善质量管理体系

2020-07-23

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

关于公开征求《抗肿瘤药联合治疗临床试验技术指导原则》意见的通知

2020-07-19

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

FDA批准抗肿瘤药物PI3Kα抑制剂CYH33临床试验

2020-06-28

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

FDA批准抗肿瘤药物IDH1抑制剂HH2301临床试验

2020-06-28

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

FDA指南简介：拓展队列用于首次人体试验加速抗肿瘤药物/生物制剂的开发

2020-05-13

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

抗肿瘤药物临床试验中风险评估与应对措施的探讨

2020-03-31

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

抗肿瘤药物临床试验的特点和医学伦理问题

2020-03-31

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

林根教授谈新冠肺炎疫情逐步控制下肺癌患者的诊疗建议，推荐合适的患者接受口服抗肿瘤药物治疗

2020-03-19

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

新型抗肿瘤药物临床应用指导原则（2019版）

2020-03-18

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

抗肿瘤药临床试验的统计设计分析

2020-03-18

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

王子平教授：力争防控同时保证肿瘤患者能够有序诊疗，安罗替尼等口服抗肿瘤药物在疫情期间发挥重要作用

2020-03-13

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

2019 年 FDA 批准上市的抗肿瘤药

2020-01-07

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

新型抗肿瘤药物临床应用指导原则（2019年版）

2019-12-22

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

可及性实用性兼具升级版《消化系统抗肿瘤药物合理用药指南》在京发布

2019-12-17

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

抗肿瘤药联合用药的早期临床方案设计思路及主要问题｜2019DDI

2019-11-01

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

2019 CSCO 大咖发声：国内自主研发抗肿瘤药物研发“全面开花”

2019-10-17

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

2019 CSCO 大咖发声：国内自主研发抗肿瘤药物研发“全面开花”

2019-10-16

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

抗肿瘤药物处方审核专家共识——结直肠癌

2019-09-30

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

BMJ：2014-16年间EMA批准抗肿瘤药物临床关键试验偏倚风险研究

2019-09-25

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

Lancet Oncol：FDA批准抗肿瘤药物临床试验质量分析

2019-07-11

科室
- - 订阅+
  - 更多科室
工具
服务